An Exploratory Study to Identify Factors Associated with Recurrence of Generalized Pustular Psoriasis Flares in Adult Patients in Japan
Authors:
- Akimichi MoritaAMAkimichi Morita
- Yukari OkuboYOYukari Okubo
- Ryuhei OkuyamaRORyuhei Okuyama
- Yoko MizutaniYMYoko Mizutani
- Nobuo KanazawaNobuo Kanazawa
- Atsushi OtsukaAOAtsushi Otsuka
- Takuya MiyagiTMTakuya Miyagi
- Masao ShionoyaMSMasao Shionoya
- Reina MizunoRMReina Mizuno
- Morihisa SaitohMSMorihisa Saitoh
- Shinichi ImafukuSIShinichi Imafuku
Open Access
- 20 April 2026
- journal article
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 106
Abstract
Generalized pustular psoriasis (GPP) is a rare, systemic inflammatory disease characterized by a heterogeneous and often unpredictable clinical course involving chronic symptoms and recurrent flares. Due to the rarity of GPP, our understanding of factors associated with flare recurrence remains unclear. Using an existing data set of adult patients with GPP in Japan, we performed univariate and multivariate analyses to investigate potential factors related to GPP flare recurrence, including patient demographics, treatment and severity of baseline flare. In total, 150 patients with a baseline flare were included in this analysis; 27.3% (n=41) experienced flare recurrence during the follow-up period (mean duration: 4.16 years). For the overall population, 56.0% of patients were male (n=84), the mean age at baseline was 55.5 years, and the mean body mass index was 24.3 kg/m2. Based on the Cox proportional hazards model, comorbid diabetes mellitus, a fever of ≥38.5°C at baseline flare, experience of flare(s) prior to baseline and certain respiratory infections were associated with a higher risk of flare recurrence, similar to previously published findings. These results could help identify patients at risk of GPP flares; however, clinically applicable prediction of GPP flares requires further research in a wider population.Keywords
This publication has 31 references indexed in Scilit:
- A Global Assessment of Patient Experience and Quality of Life in Generalized Pustular Psoriasis: Results from Interviews and Online SurveysDermatology and Therapy, 2025
- Generalized pustular psoriasis: immunological mechanisms, genetics, and emerging therapeuticsTrends in Immunology, 2024
- International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis CouncilJAMA Dermatology, 2024
- Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World EvidenceDermatology and Therapy, 2024
- Generalized pustular psoriasis: A consensus statement from the National Psoriasis FoundationJournal of the American Academy of Dermatology, 2023
- Assessment of flare frequency and severity of generalized pustular psoriasis in Japanese patients: A retrospective chart review studyJEADV Clinical Practice, 2023
- Clinical Course and Characteristics of Generalized Pustular PsoriasisAmerican Journal of Clinical Dermatology, 2022
- Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online SurveyAmerican Journal of Clinical Dermatology, 2022
- Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry DermatologistsDermatology and Therapy, 2021
- Serum IL‐36 cytokines levels in type 2 diabetes mellitus patients and their association with obesity, insulin resistance, and inflammationJournal of Clinical Laboratory Analysis, 2020